Literature DB >> 14674606

Adenovirus vectors: biology, design, and production.

M J Imperiale1, S Kochanek.   

Abstract

The use of adenovirus as a gene transfer vehicle arose from early reports of recombinant viruses carrying heterologous DNA fragments. Adenovirus vectors offer many advantages for gene delivery: they are easy to propagate to high titers, they can infect most cell types regardless of their growth state, and in their most recent embodiments they can accommodate large DNA inserts. In this chapter, the development of adenovirus vectors is reviewed, from the use of so-called first-generation, E1-deleted viruses to the latest generation high-capacity, helper-dependent vectors. Examples of their use in the clinic are described, as are the current areas in which improvements to these vectors are being explored.

Mesh:

Year:  2004        PMID: 14674606     DOI: 10.1007/978-3-662-05599-1_10

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  12 in total

Review 1.  Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.

Authors:  Jaesung Kim; Pyung-Hwan Kim; Sung Wan Kim; Chae-Ok Yun
Journal:  Biomaterials       Date:  2011-12-03       Impact factor: 12.479

2.  Transposon-assisted cloning and traceless mutagenesis of adenoviruses: Development of a novel vector based on species D.

Authors:  Zsolt Ruzsics; Markus Wagner; Andrea Osterlehner; Jonathan Cook; Ulrich Koszinowski; Hans-Gerhard Burgert
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 3.  Novel molecular approaches to cystic fibrosis gene therapy.

Authors:  Tim W R Lee; David A Matthews; G Eric Blair
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

4.  Development and assessment of human adenovirus type 11 as a gene transfer vector.

Authors:  Daniel Stone; Shaoheng Ni; Zong-Yi Li; Anuj Gaggar; Nelson DiPaolo; Qinghua Feng; Volker Sandig; André Lieber
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Adenovirus RIDalphabeta complex inhibits lipopolysaccharide signaling without altering TLR4 cell surface expression.

Authors:  Fernando Delgado-Lopez; Marshall S Horwitz
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer.

Authors:  Natalya Belousova; Galina Mikheeva; Juri Gelovani; Victor Krasnykh
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

7.  The 5'-end heterogeneity of adenovirus virus-associated RNAI contributes to the asymmetric guide strand incorporation into the RNA-induced silencing complex.

Authors:  Ning Xu; Sofia Gkountela; Khalid Saeed; Göran Akusjärvi
Journal:  Nucleic Acids Res       Date:  2009-09-15       Impact factor: 16.971

Review 8.  Perspectives on the use of gene therapy for chronic joint diseases.

Authors:  Steven C Ghivizzani; Elvire Gouze; Jean-Noel Gouze; Jesse D Kay; Marsha L Bush; Rachael S Watson; Padraic P Levings; David M Nickerson; Patrick T Colahan; Paul D Robbins; Christopher H Evans
Journal:  Curr Gene Ther       Date:  2008-08       Impact factor: 4.391

9.  Generation of cell lines to complement adenovirus vectors using recombination-mediated cassette exchange.

Authors:  Susan J Morris; Daniel C Farley; Keith N Leppard
Journal:  BMC Biotechnol       Date:  2010-12-23       Impact factor: 2.563

Review 10.  Gene therapy of the rheumatic diseases: 1998 to 2008.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.